Guy E H M Rutten Selected Research

Guy E H M Rutten Research Topics

Disease

33	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2002
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2010
6	Glucose Intolerance 11/2013 - 06/2007
4	Heart Failure 03/2013 - 08/2008
3	Body Weight (Weight, Body) 02/2015 - 09/2011
3	Myocardial Infarction 12/2014 - 04/2010
3	Stroke (Strokes) 03/2012 - 04/2010
2	Cognitive Dysfunction 01/2019 - 04/2015
2	Insulin Resistance 01/2016 - 09/2011
2	Unstable Angina 04/2010 - 04/2010
2	Pneumonia (Pneumonitis) 08/2008 - 09/2007
1	Hyperglycemia 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Diabetes Complications 01/2017
1	Inflammation (Inflammations) 10/2015
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 02/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2014
1	Atrial Fibrillation 11/2013
1	Hypertension (High Blood Pressure) 11/2013
1	Coronary Disease (Coronary Heart Disease) 08/2013
1	Diabetes Mellitus 10/2012
1	Ischemic Stroke 03/2012
1	Infections 04/2011
1	Urinary Tract Infections (Urinary Tract Infection) 08/2010
1	Hypoglycemia (Reactive Hypoglycemia) 04/2010
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010
1	Systolic Heart Failure 12/2009
1	Weight Gain 05/2009
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2008
1	Human Influenza (Influenza) 08/2006
1	Fatigue 04/2005
1	Obesity 03/2002
1	Diabetic Foot 03/2002

Drug/Important Bio-Agent (IBA)

13	Insulin (Novolin)FDA Link 01/2020 - 03/2002
10	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 06/2007
7	CholesterolIBA 10/2015 - 04/2010
4	Metformin (Glucophage)FDA LinkGeneric 01/2016 - 05/2009
4	Nateglinide (Starlix)FDA LinkGeneric 11/2013 - 04/2010
4	Valsartan (Vals)FDA Link 11/2013 - 04/2010
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2011 - 08/2008
2	SDMIBA 01/2022 - 02/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 12/2014
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 04/2015 - 02/2015
2	LipidsIBA 02/2015 - 09/2011
1	A-factor (Streptomyces)IBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 10/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2016
1	LDL CholesterolIBA 01/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	AdiponectinIBA 10/2015
1	C-Reactive ProteinIBA 10/2015
1	Retinaldehyde (Retinal)IBA 07/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2013
1	Antihypertensive Agents (Antihypertensives)IBA 08/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2013
1	AlbuminsIBA 03/2013
1	CreatinineIBA 03/2013
1	Blood Glucose (Blood Sugar)IBA 10/2012
1	FructosamineIBA 09/2011
1	Short-Acting InsulinIBA 04/2010
1	SecretagoguesIBA 04/2010
1	Adenosine Triphosphate (ATP)IBA 01/2010
1	pro-brain natriuretic peptide (1-76)IBA 12/2009
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 05/2009
1	Prednisone (Sone)FDA LinkGeneric 08/2008
1	cyclo(Arg-Pro) (CI 4)IBA 09/2007
1	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2006
1	mesoglycanIBA 08/2006
1	VaccinesIBA 08/2006
1	Dietary Fats (Dietary Fat)IBA 03/2004
1	Tolbutamide (Orinase)FDA LinkGeneric 01/2004
1	Acarbose FDA LinkGeneric 01/2004
1	Indicators and Reagents (Reagents)IBA 04/2003

Therapy/Procedure

11	Therapeutics 01/2021 - 03/2002
3	Glycemic Control 01/2020 - 08/2015
2	Polypharmacy 07/2013 - 11/2009
1	Secondary Prevention 12/2014
1	Aftercare (After-Treatment) 10/2014
1	Home Nursing (Nursing, Home) 03/2002
1	Surgical Amputation (Amputations) 03/2002